CKD-341
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
May 28, 2024
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=51 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Active, not recruiting ➔ Completed
Trial completion • Cardiovascular • Hypertension
April 02, 2024
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Active, not recruiting | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular • Hypertension
February 28, 2024
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Cardiovascular • Hypertension
February 05, 2024
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Cardiovascular • Hypertension
June 27, 2023
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Cardiovascular • Hypertension
March 22, 2023
Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=30 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Cardiovascular • Hypertension
October 07, 2022
Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Cardiovascular • Hypertension
1 to 7
Of
7
Go to page
1